CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack (DG59)Product type:GuidanceProgramme:Diagnostics guidancePublished: 31 July 2024
Tenecteplase for treating acute ischaemic stroke (TA990)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 July 2024
Artificial intelligence (AI)-derived software to help clinical decision making in stroke (DG57)Product type:GuidanceProgramme:Diagnostics guidanceLast updated: 2 May 2024Published: 23 January 2024
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)Product type:GuidanceProgramme:NICE guidelinePublished: 14 December 2023
Percutaneous transarterial carotid artery stent placement for asymptomatic extracranial carotid stenosis (IPG777)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 November 2023
Stroke rehabilitation in adults (NG236)Product type:GuidanceProgramme:NICE guidelinePublished: 18 October 2023
Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides (TA805)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 July 2022
Stroke and transient ischaemic attack in over 16s: diagnosis and initial management (NG128)Product type:GuidanceProgramme:NICE guidelineLast updated: 13 April 2022Published: 1 May 2019
Inducing and maintaining normothermia using temperature modulation devices to improve outcomes after stroke or subarachnoid haemorrhage (IPG701)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 July 2021
Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA275)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 27 February 2013
Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA355)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 2 July 2021Published: 23 September 2015
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke (DG41)Product type:GuidanceProgramme:Diagnostics guidancePublished: 2 September 2020
Therapeutic hypothermia for acute ischaemic stroke (IPG647)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 29 May 2019
Extracranial to intracranial bypass for intracranial atherosclerosis (IPG596)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 8 November 2017
Ticagrelor for preventing atherothrombotic events after myocardial infarction (TA420)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 December 2016
Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting (IPG561)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 June 2016
Mechanical clot retrieval for treating acute ischaemic stroke (IPG548)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 February 2016
Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events (IPG472)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 18 December 2013
Alteplase for treating acute ischaemic stroke (TA264)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 September 2012
Endovascular stent insertion for intracranial atherosclerotic disease (IPG429)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 July 2012
Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation (TA256)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 23 May 2012
Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation (TA249)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 15 March 2012
Cardiovascular disease prevention (PH25)Product type:GuidanceProgramme:Public health guidelinePublished: 22 June 2010
ReStore Soft Exo-Suit for gait rehabilitation (MIB239)Product type:AdviceProgramme:Medtech innovation briefingPublished: 15 December 2020
IQoro for stroke-related dysphagia (MIB175)Product type:AdviceProgramme:Medtech innovation briefingPublished: 6 March 2019
Mechanical thrombectomy devices for acute ischaemic stroke (MIB153)Product type:AdviceProgramme:Medtech innovation briefingPublished: 30 July 2018
Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysis (MIB93)Product type:AdviceProgramme:Medtech innovation briefingPublished: 18 January 2017
Cardiovascular risk assessment and lipid modification (QS100)Product type:Quality standardLast updated: 24 May 2023Published: 4 September 2015
Stroke in adults (QS2)Product type:Quality standardLast updated: 12 April 2016Published: 29 June 2010
Cardiovascular risk assessment and lipid modificationStatus:In development | In consultationConsultation end date: 25 March 2025Expected publication date: 23 July 2025
Botulinum toxin type A for treating upper or lower limb focal spasticity associated with stroke [ID768]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Dabigatran etexilate for the secondary prevention of stroke after an embolic stroke of undetermined source [ID1417]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Endovascular stent insertion for intracranial atherosclerotic diseaseStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Invimestrocel for treating acute ischaemic stroke within 18 to 36 hours of onset [TSID10190]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC